BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30305125)

  • 1. Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.
    Nakajima K; Iwata H; Ogino H; Hattori Y; Hashimoto S; Toshito T; Hayashi K; Akita K; Baba F; Nakamae K; Mizoe JE; Shibamoto Y
    Radiat Oncol; 2018 Oct; 13(1):199. PubMed ID: 30305125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.
    Nakajima K; Oguri M; Iwata H; Hattori Y; Hashimoto S; Nomura K; Hayashi K; Toshito T; Akita K; Baba F; Ogino H; Hiwatashi A
    Radiother Oncol; 2024 Jul; 196():110276. PubMed ID: 38614284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
    Kanemoto A; Okumura T; Ishikawa H; Mizumoto M; Oshiro Y; Kurishima K; Homma S; Hashimoto T; Ohkawa A; Numajiri H; Ohno T; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Clin Lung Cancer; 2014 Mar; 15(2):e7-12. PubMed ID: 24365049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer.
    Shioyama Y; Tokuuye K; Okumura T; Kagei K; Sugahara S; Ohara K; Akine Y; Ishikawa S; Satoh H; Sekizawa K
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):7-13. PubMed ID: 12694818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer.
    Iwata H; Demizu Y; Fujii O; Terashima K; Mima M; Niwa Y; Hashimoto N; Akagi T; Sasaki R; Hishikawa Y; Abe M; Shibamoto Y; Murakami M; Fuwa N
    J Thorac Oncol; 2013 Jun; 8(6):726-35. PubMed ID: 23459403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
    Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
    J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy.
    Chen J; Lu JJ; Ma N; Zhao J; Chen C; Fan M; Jiang G; Mao J
    Radiat Oncol; 2019 Jan; 14(1):16. PubMed ID: 30683133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.
    Oshiro Y; Mizumoto M; Okumura T; Hashimoto T; Fukumitsu N; Ohkawa A; Kanemoto A; Hashii H; Ohno T; Sakae T; Tsuboi K; Sakurai H
    J Thorac Oncol; 2012 Feb; 7(2):370-5. PubMed ID: 22157368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
    Hasselle MD; Haraf DJ; Rusthoven KE; Golden DW; Salgia R; Villaflor VM; Shah N; Hoffman PC; Chmura SJ; Connell PP; Vokes EE; Weichselbaum RR; Salama JK
    J Thorac Oncol; 2012 Feb; 7(2):376-81. PubMed ID: 22198429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.
    Nagata Y; Hiraoka M; Shibata T; Onishi H; Kokubo M; Karasawa K; Shioyama Y; Onimaru R; Kozuka T; Kunieda E; Saito T; Nakagawa K; Hareyama M; Takai Y; Hayakawa K; Mitsuhashi N; Ishikura S
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):989-96. PubMed ID: 26581137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.
    Westover KD; Loo BW; Gerber DE; Iyengar P; Choy H; Diehn M; Hughes R; Schiller J; Dowell J; Wardak Z; Sher D; Christie A; Xie XJ; Corona I; Sharma A; Wadsworth ME; Timmerman R
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):72-81. PubMed ID: 26279026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.
    Chang JY; Zhang W; Komaki R; Choi NC; Chan S; Gomez D; O'Reilly M; Jeter M; Gillin M; Zhu X; Zhang X; Mohan R; Swisher S; Hahn S; Cox JD
    Radiother Oncol; 2017 Feb; 122(2):274-280. PubMed ID: 28139305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP; Herschtal A; Wheeler G; Mac Manus M; Wirth A; Michael M; Hogg A; Drummond E; Ball D
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1371-5. PubMed ID: 19250769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.